CD274 and neoplasm: Interestingly, in vitro studies have demonstrated that lenalidomide treatment reduces PD-1 expression on T and NK cells and PD-L1 expression on tumor plasma cells and MDSCs (86) suggesting that IMiDs could enhance the effect of the ICP inhibitor (139).